Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
The Global Fund pools money from governments and donors and gives it as grants to countries fighting AIDS, tuberculosis, and malaria.
The Global Fund is one of the world's biggest funders of the fight against three deadly diseases. It does not treat patients itself. Instead, it collects money from governments, foundations, and private donors, then hands out grants to countries so they can buy medicines, test kits, mosquito nets, and pay the health workers who run these programs. Think of it as a giant money pool for global health: rich countries and donors put money in, and poor countries with heavy disease burdens draw it out to fund their own fight.
The problem it exists to solve is simple. AIDS, tuberculosis, and malaria kill millions of people, mostly in poorer parts of the world, and those countries often cannot afford the drugs and prevention tools on their own. The Fund was created in 2002 as a partnership between governments, civil society, and the private sector, and it is headquartered in Geneva, Switzerland. Countries apply for grants by presenting a plan for how they will use the money, and the Fund tracks whether the results actually happen. The people who pay are mostly wealthy governments, led by the United States, along with European countries, Japan, and private givers like the Gates Foundation. The recipients are low- and middle-income countries, which use the money for things like antiretroviral therapy for people living with HIV, bed nets to stop malaria-carrying mosquitoes, and testing and treatment for tuberculosis. Since its founding, the Fund says its programs have saved tens of millions of lives. What makes it strong is its scale and its results-based model: it ties money to measurable outcomes rather than just cutting checks. What makes it vulnerable is that it depends entirely on donors continuing to give. It raises money in multi-year cycles, and its replenishment rounds — the periodic appeals for the next chunk of funding — can make or break how many people get treatment. When donor budgets tighten or political priorities shift, the Fund feels it directly.
It is a nonprofit, not a company, so it has no shares, no dividends, and no profit to distribute. Its "business" is moving donor money into health programs as efficiently as possible, and its scorecard is lives saved rather than earnings.
Saved answer · last researched 15 Nov 2026